| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/02/2004 | EP1423098A1 A new extended release oral dosage form |
| 06/02/2004 | EP1423012A2 Isolation and mobilization of stem cells expressing vegfr-1 |
| 06/02/2004 | EP1326613B1 Use of substituted imidazo 1,2-a]pyridine-, imidazo [1,2-a]pyrimidine and imidazo [1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments |
| 06/02/2004 | EP1274405B1 Transdermal or transmucosal dosage forms with a nicotine-containing active substance combination for smoker disintoxication |
| 06/02/2004 | EP1267832B1 SELF EMULSIFYING DRUG DELIVERY SYSTEM, wherein the fatty agent is optional |
| 06/02/2004 | EP1259510B1 Tricyclic dihydropyrazolone and tricyclic dihydroisoxazolone potassium channel openers |
| 06/02/2004 | EP1244614B1 Tryptase inhibitors |
| 06/02/2004 | EP1242109A4 A method for treating viral diseases and other disorders by altering immediate gene expression through administration of peptide t |
| 06/02/2004 | EP1227824B1 Transplant/implant device and method for its production |
| 06/02/2004 | EP1204662B1 Azaindoles having serotonin receptor affinity |
| 06/02/2004 | EP1171113B1 Compounds useful as phosphotyrosine mimics |
| 06/02/2004 | EP1143971B1 Substituted 1-(piperidin-4-yl)-3-(aryl)-isothioureas, their preparation and therapeutic use |
| 06/02/2004 | EP1063978B1 Method of treating neuroma pain |
| 06/02/2004 | CN1501976A Crf2 ligands in combination therapy |
| 06/02/2004 | CN1501941A Chemical compounds |
| 06/02/2004 | CN1501940A Composition and method for inhibiting platelet aggregation |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501932A Tricyclic diazepines as tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501931A Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501930A Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501927A Trifluoromethylpurines as phosphodiesterase 4 inhibitors |
| 06/02/2004 | CN1501922A Remedies |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501911A Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/02/2004 | CN1501910A Crystalline forms of venlafaxine hydrochloride |
| 06/02/2004 | CN1501909A Novel succinate salt of o-desmethyl-venlafaxine |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501815A New interferon beta-like molecules |
| 06/02/2004 | CN1501813A Visual function improving agents |
| 06/02/2004 | CN1501806A Method for preparing an extract of ginkgo biloba leaves highly enriched in active principles |
| 06/02/2004 | CN1501800A Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of cns disorders and a process for the preparation thereof |
| 06/02/2004 | CN1501798A Medicinal compositions comprising diclofenac and ornoprostil |
| 06/02/2004 | CN1501795A Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 06/02/2004 | CN1500810A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500809A Fibroblast growth factor-2 analogue, producing process and application thereof |
| 06/02/2004 | CN1500781A Inhibitors of interleukin-1 beta converting enzyme |
| 06/02/2004 | CN1500773A Cyclic amino acids and derivatives thereof useful as pharmaceutical agents |
| 06/02/2004 | CN1500524A Vehicle for topical delivery of anti-inflammatory compounds |
| 06/02/2004 | CN1500513A Instant traditional Chinese medicine formulation for headache |
| 06/02/2004 | CN1500512A Traditional Chinese medicine for insomnia |
| 06/02/2004 | CN1500509A Traditional Chinese medicine composition for blahs and anxiety |
| 06/02/2004 | CN1500489A Notoginseng drop pills for calming nerve and curing insomnia etc. and preparation method |
| 06/02/2004 | CN1500484A Use of atropin in preparation of drug-relief medicine |
| 06/02/2004 | CN1500483A Novel use of phencynonate hydrochloride |
| 06/02/2004 | CN1152049C Treatment of insulin resistance with growth hormone secretagogues |
| 06/02/2004 | CN1152042C Partial or full A agonists-N heterocyclic 5' thio substituted adenosine devivatives |
| 06/02/2004 | CN1152030C Novel heterocyclic compounds |
| 06/02/2004 | CN1152021C Intermediate for preparing corticotropin release factors antagonistic agent and preparing method thereof |
| 06/02/2004 | CN1152016C 2-(3,5-bi-trifluoromethyl-phenyl)-N methyl-N-(6-morpholine-4-yl-4-o-tolyl-pyridine-3-yl)-isobutyramide |
| 06/02/2004 | CN1152006C Biphenyl derivatives |
| 06/02/2004 | CN1151834C Pure traditional Chinese drug-relief medicine and its preparation method |
| 06/02/2004 | CN1151827C Dressed plaster for treating facial palsy and its preparation |
| 06/02/2004 | CN1151813C Traditional Chinese medicine composition for curing insomnia |
| 06/02/2004 | CN1151800C Medicine for curing diabetic peripheral nervous lesion |
| 06/02/2004 | CN1151797C Tumor-blood-vessel growth inhibitor and medicinal composition |
| 06/02/2004 | CN1151789C Use of aryl (or heteroaryl) pyrrolyl methanol derivatives |
| 06/02/2004 | CN1151787C Lactacystine analogs |
| 06/02/2004 | CN1151783C Delayed-release dosage forms of sertraline |
| 06/02/2004 | CN1151778C Pharmaceutical composition comprising entacapone or nitecapone as well as cross-linked cellulose derivative |
| 06/01/2004 | USRE38524 Dipeptide derivatives as growth hormone secretagogues |
| 06/01/2004 | US6743949 Process of obtainment of racemic cetamine enantiomers; process of obtainment of pharmaceutically acceptable salts from racemic cetamine enantiomes and use of pharmaceutically acceptable salts obtained by means of said mentioned process |
| 06/01/2004 | US6743939 Phenylheteroalkylamine derivatives |
| 06/01/2004 | US6743824 Administering selegiline to patient in an amount sufficient to prevent, reduce or eliminate one or more of the symptoms associated with peripheral neuropathy |
| 06/01/2004 | US6743818 Treating anxiety, panic attacks, obsessive-compulsive disorders, phobias, impulsive disorders, drug abuse, cognitive disorders, psychoses, depression and mood disorders |
| 06/01/2004 | US6743817 Substituted fused pyrroleimines and pyrazoleimines |
| 06/01/2004 | US6743816 Imidazole derivatives with anti-inflammatory activity |
| 06/01/2004 | US6743815 Estrogen receptor modulators |
| 06/01/2004 | US6743812 Pharmaceutical compositions and methods for use |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743809 Indole Derivatives useful for the treatment of CNS disorders |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743803 Medicines for the prevention and treatment of neurodegenerative diseases |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743791 Heterocyclic inhibitors of ERK2 and uses thereof |
| 06/01/2004 | US6743789 Substituted imidazo[1,5-a][1,2,4]triazolo[4,3-d][1,4]benzodiazepine derivatives |
| 06/01/2004 | US6743788 Carbamate and oxamide compounds |
| 06/01/2004 | US6743441 Controlling concentration; side effect reduction |
| 06/01/2004 | US6743415 Delivery of anti-migraine compounds through an inhalation route |
| 06/01/2004 | CA2146646C Benzopyranones, method of preparing them and their use |
| 05/27/2004 | WO2004044204A2 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 05/27/2004 | WO2004043982A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 05/27/2004 | WO2004043968A1 N-sulfonylaminothiazole |
| 05/27/2004 | WO2004043967A1 Spirocyclic cyclohexane derivatives |
| 05/27/2004 | WO2004043960A1 1,4-diazabicyclo (3,2,2)nonane derivatives, preparation and therapeutical use thereof |
| 05/27/2004 | WO2004043958A1 Fused heterocyclic compounds |
| 05/27/2004 | WO2004043952A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |
| 05/27/2004 | WO2004043949A1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 05/27/2004 | WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/27/2004 | WO2004043931A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors |
| 05/27/2004 | WO2004043909A1 Cyclohexylurea derivatives |
| 05/27/2004 | WO2004043907A1 Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same |
| 05/27/2004 | WO2004043904A1 3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin and norephinephrine reuptake |
| 05/27/2004 | WO2004043903A1 3-aryloxy/ thio-2, 3-substituted propanamines and their use in inhibiting serotonin and norepinephrine reuptake |
| 05/27/2004 | WO2004043900A2 4-alkyl/4-alkenyl/4-alkynyl methyl/-1-arylcyclohexylamine derivatives |
| 05/27/2004 | WO2004043491A1 Remedies for vertebral canal stenosis |
| 05/27/2004 | WO2004043483A1 A method for treating spinal cord injury |
| 05/27/2004 | WO2004043475A1 Agent for improving learning and memorizing abilities |
| 05/27/2004 | WO2004043465A1 Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions |
| 05/27/2004 | WO2004043460A1 Synergistic combinations with analgesic properties comprising n-acylated 4-hydroxyphenylamine derivatives |
| 05/27/2004 | WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands |